Eurofins Scientific Stock

Eurofins Scientific SA, a life sciences company, provides analytical testing services to clients from various industries, including the pharmaceutical, food, and environmental sectors internationally. The company specializes in delivering analytical testing services to clients from industries, including the pharmaceutical, biotechnology, food, and environmental sectors.

The company operates approximately 50 laboratories across 15 countries, through which it offers a portfolio of approximately 10,000 analytical methods for evaluating the authenticity, origin, safety, identity, composition and purity of biological substances and products. The company principally markets its services in seven geographical areas: Benelux, France, Germany, North America, Scandinavia, and British Isles, including United Kingdom and Republic of Ireland.

Services

Food Analysis: The company offers its customers a broad spectrum of quality, purity and authenticity analysis at all stages of food and consumable goods processing. Its services include analysis of vitamins, foodstuffs and minerals, microbiological examination, analysis of additives, residues and contamination or the characterization of aromatics.

Biotechnology: The company provides bioanalytical services for the development of new products, purity analyses and substance stability studies and also supports them in the implementation of pre-clinical studies.

Environment: services include analyses of soil, waste water, air and construction materials and residues.

Product Testing: The company performs chemical, biological, physical and sensorial testing for consumer products, construction products, and some industrial products.

During 2004, Eurofins acquired the laboratory ADME Bioanalyses (Montpellier, France) to complement its Pharma business serving the pharmaceutical industry. ADME premises are specially designed to optimize efficiency and safety for conducting pharmacokinetic and metabolic fate studies.

The company’s biomarker discovery and bioanalytical services laboratory in Aurora would provide mass spectrometry-based technologies for the development, validation and measurement of biomarkers and biomarker strategies, including targeted and non-targeted biochemical profiling and protein profiling. The laboratory would offer the development and validation of assays for the quantification of endogenous compounds, drugs and their metabolites, as well as bioanalytical services for all stages of drug development.